DSE

gene product
DSEPI, SART2
The protein encoded by this gene is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. This gene product is localized to the endoplasmic reticulum. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
75 antibodies from 18 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
26 antibodies
NovoPro Bioscience Inc.
2 antibodies
Proteintech Group
2 antibodies
Novus Biologicals
3 antibodies
Abnova Corporation
5 antibodies
Atlas Antibodies
2 antibodies
Invitrogen Antibodies
2 antibodies
Biorbyt
11 antibodies
Abgent
1 antibody
RabMAbs
1 antibody
LifeSpan BioSciences, Inc.
8 antibodies
Affinity Biosciences
1 antibody
GeneTex
1 antibody
Creative Biolabs
3 antibodies
Sigma-Aldrich
2 antibodies
Abbexa
3 antibodies
Creative Diagnostics
1 antibody
United States Biological
1 antibody